Wyeth Should Face Drug Rebate Claims In Court, States Say
By Dani Kass · October 22, 2015, 4:20 PM EDT
Several states intervening in a whistleblower suit accusing Pfizer-owned Wyeth Pharmaceuticals of overcharging Medicaid by hundreds of millions of dollars for an acid reflux drug told a Massachusetts federal court Wednesday...
To view the full article, register now.